Results 91 to 100 of about 6,002 (227)

Patient specific quality control for Stereotactic Ablative Body Radiotherapy (SABR): it takes more than one phantom [PDF]

open access: diamond, 2017
Tomas Kron   +9 more
openalex   +1 more source

Stereotactic Ablative Radiation Therapy for Metastatic Renal Cell Carcinoma – A Review of Evidence

open access: yesActa Medica Lituanica
Because of its remarkable precision in providing targeted radiation, recent evidence supports Stereotactic Ablative Radiation Therapy (SABR) as a promising non-invasive treatment approach for metastatic renal cell carcinoma, minimizing harm to adjacent ...
Hima Bora   +2 more
doaj   +1 more source

Stereotactic ablative radiotherapy for primary kidney cancer – An international patterns of practice survey

open access: yesClinical and Translational Radiation Oncology
Purpose: To conduct an international survey of radiation oncologists treating primary renal cell carcinoma (RCC) with SABR to ascertain the general patterns of SABR use, common dose/treatment/follow-up details, and expected outcomes.
Katherine Taplin   +7 more
doaj   +1 more source

SABR-Dual: a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer

open access: yesBMC Cancer
Background Dose-escalated radiotherapy is known to improve progression free survival in patients with localized prostate cancer, and recent advances have led to the standardization of ultrahypofractionated stereotactic ablative radiotherapy (SABR ...
Elisha Fredman   +6 more
doaj   +1 more source

SABR improves outcomes [PDF]

open access: yesNature Reviews Clinical Oncology, 2019
openaire   +2 more sources

PO-0882 Outcome and Toxicity of Hypofractionated Image-Guided SABR for Spinal Oligometastases

open access: bronze, 2019
Charlotte Billiet   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy